Clinical genetics in developing countries: the case of Brazil

Area of Science:

• Medical Genetics
• Public Health

Background:

• Genetic diseases and birth defects present significant global health challenges, often overlooked in developing nations prioritizing basic healthcare.
• Limited resources exacerbate the burden of genetic conditions on individuals, families, and populations in lower-income settings.
• Advances in medical genetics increase demand for specialized services, highlighting the need for integrated prevention and management programs.

Purpose of the Study:

• To provide an overview of the challenges and status of clinical and medical genetics in Brazil.
• To discuss proposals for developing equitable and ethically sound genetic services within the Brazilian healthcare system.

Main Methods:

• Review of the Brazilian health system's structure and evolution.
• Analysis of the development and current state of medical and clinical genetics services in Brazil.
• Discussion of ethical considerations and proposals for service implementation.

Main Results:

• Brazil, like other developing countries, faces obstacles in prioritizing genetic diseases due to competing health needs.
• Despite challenges, there's a growing demand for genetic services, necessitating strategic planning.
• The study outlines specific issues within Brazil's health system affecting genetic care delivery.

Conclusions:

• Implementing accessible, ethical, and equitable clinical genetic services is crucial for the Brazilian population.
• Addressing the unique context of developing countries is essential for effective genetic disease management and prevention programs.
• Integrating genetic services at the primary healthcare level is a key recommendation for Brazil.